REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420,985 | -35.6% | 15,209 | -44.6% | 0.02% | -54.3% |
| Q4 2022 | $654,002 | -47.4% | 27,456 | -57.0% | 0.04% | -35.2% |
| Q2 2022 | $1,243,000 | -28.2% | 63,800 | -5.9% | 0.05% | -27.0% |
| Q1 2022 | $1,730,000 | +187.4% | 67,800 | +183.7% | 0.07% | +94.7% |
| Q4 2021 | $602,000 | +8.5% | 23,900 | +70.5% | 0.04% | -59.6% |
| Q4 2020 | $555,000 | – | 14,016 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |